Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
451. |
ECCT/23/05/01 | A5356 A Phase II, Prospective, Randomized, Multicenter Trial to Evaluate the Efficacy and Safety/Tolerability of Two Linezolid Dosing Strategies in Combination with a Short Course Regimen for the Treatment of Drug-Resistant Pulmonary Tuberculosis |
Principal Investigator(s) 1. Abraham Mosigisi Siika Site(s) in Kenya MOI UNIVERSITY CLINICAL RESEARCH CENTRE |
06-03-2024 |
View |
452. |
ECCT/23/05/06 | Sildenafil citrate to improve Sildenafil citrate to improve maternal and neonatal outcomes in low-resource settings: a randomized feasibility trial |
Principal Investigator(s) 1. Nora Switchenko Site(s) in Kenya NAKURU COUNTY REFERRAL AND TEACHING HOSPITAL |
05-07-2024 |
View |
453. |
ECCT/12/11/01 | Prospective Observational Study of Male Circumcision Using the PrePex Device in Routine Clinical Settings in Kenya |
Principal Investigator(s) 1. Robert Bailey 2. Peter Cherutich 3. Walter Obiero 4. Elijah Odoyo June Site(s) in Kenya The Nyanza Reproductive Health Society UNIM clinic in Kisumu with assistance from NRHS’s mobile outreach service providers in Rachuonyo. |
02-11-2012 |
View |
454. |
ECCT/19/11/05 | Point-of-care Urine Monitoring of Adherence (PUMA) Point-of-care Urine Monitoring of Adherence (PUMA): Testing a Real-Time Urine Assay of Tenofovir in PrEP Pilot trial to examine the feasibility, acceptability and impact on longer-term adherence of an intervention using a new urine-based tenofovir adherence assay |
Principal Investigator(s) 1. Nelly Rwamba Mugo Site(s) in Kenya KEMRI-CCR PHRD (THIKA) PROJECT |
15-04-2020 |
View |
455. |
ECCT/21/09/02 | PrEDIRA - 2 Piloting HIV Pre-exposure Prophylaxis (PrEP) Integration into Services for Early Pregnancy Loss |
Principal Investigator(s) 1. Nelly Rwamba Mugo Site(s) in Kenya 1. KEMRI-CCR PHRD THIKA - Thika, Nairobi, Murang\'a, and their environs (Kiambu county) 2. Kisumu clinical trial site - Kisumu and its enrvirons (Kisumu county) 3. Mariestopes - Nairobi (Nairobi City county) |
23-01-2022 |
View |
456. |
ECCT/15/10/03 | Safer Conception Intervention for Partners (SCIP) Pilot of an mHealth-enhanced, safer conception intervention to reduce HIV-1 risk among Kenyan HIV-1 serodiscordant couples Safer Conception Intervention for Partners (SCIP) |
Principal Investigator(s) 1. Nelly Rwamba Mugo Site(s) in Kenya Thika Partners Study Clinic (Partners in Health Research and Development) affiliated to the University of Washington International Clinical Research Center (ICRC), and KEMRI |
11-01-2016 |
View |
457. |
ECCT/18/07/02 | CONRAD RING Phase IIa, 90-Day Safety, Adherence, and Acceptability Study of Intravaginal Rings Releasing Tenofovir with and without Levonorgestrel among Women in Western Kenya |
Principal Investigator(s) 1. DR. NELLY RWAMBA MUGO Site(s) in Kenya KEMRI CRC |
22-09-2018 |
View |
458. |
ECCT/26/02/07 | IMPAACT 2024 Phase I/II Dose Finding, Safety and Tolerability Study of Daily Rifapentine Combined with Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age with and without HIV |
Principal Investigator(s) 1. LUCY Chepkurui Koech Site(s) in Kenya Kenya Medical Research Institute/Walter Reed Project(KEMRI/WRP) |
27-08-2026 |
View |
459. |
ECCT/24/07/03 | RVF003 Trial Phase 2 trial to assess the immunogenicity and safety of the ChAdOx1 RVF vaccine against Rift Valley fever in adults in Kenya |
Principal Investigator(s) 1. George Warimwe Site(s) in Kenya KEMRI-Wellcome Trust Research Programme |
06-01-2025 |
View |
460. |
ECCT/17/05/03 | TDF IVR-002 Study Phase 1 Safety and Pharmacokinetic Study of a Polyurethane Tenofovir Disoproxil Fumarate Vaginal Ring in Sexually Active Women (TDF IVR-002) |
Principal Investigator(s) 1. Nelly Rwamba Mugo Site(s) in Kenya Partners in Health Research & Development (Thika Partners Clinical Trial Site) |
18-07-2017 |
View |